Observational studyMedicine2019

Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy.

Guan-Jhou Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.